SCHEMBL4860909

SCHEMBL4860909

Cc1cccc(-c2nc3ccccn3c2-c2ccc3nc(C)n(C)c3c2)n1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 13/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 4/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
GLA P06280 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPK14 Q16539 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MAPT P10636 1/20 0.37
TGFBR2 P37173 1/20 0.36
MAP3K20 Q9NYL2 1/20 0.36
CDK4 P11802 1/20 0.34
CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4867649 0.84 TGFBR1 (0.39) TGFBR1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL4860883 0.83 TGFBR1 (0.43) TGFBR1KDM4EALDH1A1GLAGAA
SCHEMBL4878226 0.81 TGFBR1 (0.59) TGFBR1MAPK14
SCHEMBL4859626 0.80 TGFBR1 (0.59) TGFBR1POLBMAPK14NPC1RAB9A
SCHEMBL4864322 0.79 TGFBR1 (0.40) TGFBR1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL4875633 0.78 PIK3CD (0.44) TGFBR1MAPK14
SCHEMBL23408260 0.77 TGFBR1 (0.43) TGFBR1KDM4EMAPK14NPC1RAB9A
SCHEMBL29796648 0.77 KDM4E (0.43) TGFBR1KDM4EMAPK14NPC1RAB9A
SCHEMBL23389738 0.77 KDM4E (0.43) TGFBR1KDM4EMAPK14NPC1RAB9A
SCHEMBL4863474 0.76 CDK4 (0.43) TGFBR1KDM4EALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275235-A1 NOVEL FUSED HETEROAROMATIC COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS PFIZER INC. (US) 2008-11-06 US disclosed
US-7417041-B2 Imidazopyrimidines as transforming growth factor (TGF) inhibitors PFIZER INC. (US) 2008-08-26 US disclosed
US-20040176390-A1 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors PFIZER INC 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275235-A1 NOVEL FUSED HETEROAROMATIC COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS TGFBR1, SMAD3, SMAD2 TGFBR1 1/4885KDM4E 1485/4885ALDH1A1 1680/4885
US-20040176390-A1 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors SMAD3, TGFBR1, SMAD2 TGFBR1 2/4885KDM4E 1697/4885ALDH1A1 1547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.